ST. PAUL, Minn., Nov. 8 /PRNewswire/ -- In a unanimous decision on Oct. 29, North Dakota state lawmakers, with the support of Governor John Hoeven and the state’s Centers of Excellence Commission, approved a $2.5 million grant for Enova Medical Technologies, the University of North Dakota (UND) and North Dakota State University (NDSU) to develop and manufacture an innovative thrombectomy device.
The grant will fund the Center of Excellence for Biomedical Device Research, Development and Commercialization, which will focus on Enova’s patented license for a thrombectomy device that removes clots in blood vessels. Enova will team with researchers at the UND School of Engineering, the UND School of Medicine, and North Dakota State University College of Engineering to develop the device.
The company will also work directly with the Minot Area Development Corporation to establish manufacturing operations in Minot. Due to the high market potential for this device, Enova anticipates creating several hundred jobs in the Minot area over the next two to five years.
Fariborz Boor Boor, CEO of Enova, said the grant reflects the confidence the two major North Dakota research universities have shown in Enova’s thrombectomy device, as well as the state’s willingness to promote and fund cooperative efforts between businesses and its universities.
“This partnership between Enova, the state of North Dakota, UND and NDSU, complements our vision of developing a ‘creative, collaborative community’ and will help our collective desire to develop a thrombectomy catheter that removes blood clots from stroke patients,” he said. “This collaboration will create a win-win-win situation; North Dakota wins, Enova wins, and most importantly, stroke patients will win.”
The mission of the Center of Excellence for Biomedical Device Research, Development and Commercialization is to provide the research, development, and commercialization resources for a range of biomedical devices. Over time, the Center will conduct multiple, concurrent projects for various biomedical companies and cities, thereby providing the potential for economic development throughout North Dakota and the region.
Enova Medical Technologies, a privately-held company, is engaged in the development and commercialization of proprietary medical devices and is an experienced provider of product development, manufacturing, and commercialization services for the medical device industry. From Class I to Class III devices, Enova understands the technical challenges of product design, engineering, research and development, the regulatory steps required to successfully commercialize products, and the marketing and sales efforts needed to move inventory off the shelf. For more information, visit http://www.enovamedical.com.
CONTACT: Kerstin March of Enova Medical Technologies, +1-651-773-3181,
ext. 28, kmarch@enovamedical.com
Web site: http://www.enovamedical.com/
